Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | RGD Reference | Notes | Source | Original Reference(s) | Zfp35 | Rat | 17beta-estradiol | affects expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Estradiol affects the expression of ZNF79 mRNA | CTD | PMID:14699072 | Zfp35 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP35 mRNA | CTD | PMID:32109520 | Zfp35 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP35 mRNA | CTD | PMID:33387578 | Zfp35 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZFP35 mRNA | CTD | PMID:30047161 | Zfp35 | Rat | acrylamide | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of ZNF79 mRNA | CTD | PMID:32763439 | Zfp35 | Rat | actinomycin D | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of ZNF79 mRNA | CTD | PMID:38460933 | Zfp35 | Rat | aflatoxin B1 | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ZNF79 mRNA | CTD | PMID:21641981 PMID:27153756 | Zfp35 | Rat | aflatoxin B1 | affects expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of ZNF79 protein | CTD | PMID:20106945 | Zfp35 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ZFP35 mRNA | CTD | PMID:38685447 PMID:41580965 | Zfp35 | Rat | arsane | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | arsenic atom | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | benzo[a]pyrene | affects methylation | ISO | ZNF79 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF79 promoter | CTD | PMID:27901495 | Zfp35 | Rat | benzo[a]pyrene | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ZNF79 mRNA | CTD | PMID:20064835 PMID:20106945 PMID:21632981 PMID:26238291 PMID:32234424 | Zfp35 | Rat | bisphenol A | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ZNF79 mRNA | CTD | PMID:31715268 | Zfp35 | Rat | cadmium dichloride | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ZNF79 mRNA | CTD | PMID:38568856 | Zfp35 | Rat | camptothecin | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of ZNF79 mRNA | CTD | PMID:38460933 | Zfp35 | Rat | CGP 52608 | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF79 gene] | CTD | PMID:28238834 | Zfp35 | Rat | cisplatin | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ZNF79 mRNA | CTD | PMID:19561079 | Zfp35 | Rat | crocidolite asbestos | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased expression of ZNF79 mRNA | CTD | PMID:18687144 | Zfp35 | Rat | CU-O LINKAGE | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | cupric oxide results in increased expression of ZNF79 mRNA | CTD | PMID:22077320 | Zfp35 | Rat | cyclosporin A | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ZNF79 mRNA | CTD | PMID:20106945 | Zfp35 | Rat | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of ZFP35 mRNA | CTD | PMID:23640034 | Zfp35 | Rat | doxorubicin | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ZNF79 mRNA | CTD | PMID:29803840 | Zfp35 | Rat | ethyl methanesulfonate | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ZNF79 mRNA | CTD | PMID:23649840 | Zfp35 | Rat | folic acid | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ZNF79 mRNA | CTD | PMID:24657277 | Zfp35 | Rat | formaldehyde | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ZNF79 mRNA | CTD | PMID:23649840 | Zfp35 | Rat | formaldehyde | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ZNF79 mRNA | CTD | PMID:20655997 | Zfp35 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ZFP35 mRNA | CTD | PMID:33387578 | Zfp35 | Rat | GSK-J4 | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of ZNF79 mRNA | CTD | PMID:29301935 | Zfp35 | Rat | iron dichloride | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of ZNF79 mRNA | CTD | PMID:35984750 | Zfp35 | Rat | leflunomide | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Leflunomide results in increased expression of ZNF79 mRNA | CTD | PMID:28988120 | Zfp35 | Rat | manganese atom | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | manganese(0) | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | manganese(II) chloride | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ZFP35 mRNA | CTD | PMID:30047161 PMID:38685447 PMID:41580965 | Zfp35 | Rat | methotrexate | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of ZNF79 mRNA | CTD | PMID:24657277 | Zfp35 | Rat | methotrexate | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ZNF79 mRNA | CTD | PMID:24657277 | Zfp35 | Rat | methyl methanesulfonate | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ZNF79 mRNA | CTD | PMID:23649840 | Zfp35 | Rat | Nutlin-3 | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of ZNF79 mRNA | CTD | PMID:38460933 | Zfp35 | Rat | paracetamol | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ZNF79 mRNA | CTD | PMID:22230336 | Zfp35 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZFP35 mRNA | CTD | PMID:33387578 | Zfp35 | Rat | quercetin | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Quercetin results in increased expression of ZNF79 mRNA | CTD | PMID:21632981 | Zfp35 | Rat | resorcinol | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | resorcinol results in decreased expression of ZNF79 mRNA | CTD | PMID:22623647 | Zfp35 | Rat | resveratrol | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF79 mRNA | CTD | PMID:23557933 | Zfp35 | Rat | sodium arsenite | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ZNF79 mRNA | CTD | PMID:38568856 | Zfp35 | Rat | sodium arsenite | multiple interactions | ISO | ZNF79 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Zfp35 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of ZFP35 mRNA | CTD | PMID:30047161 | Zfp35 | Rat | sunitinib | increases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ZNF79 mRNA | CTD | PMID:31533062 | Zfp35 | Rat | testosterone | decreases expression | ISO | ZNF79 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ZNF79 mRNA | CTD | PMID:33359661 | Zfp35 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ZFP35 mRNA | CTD | PMID:23411599 | Zfp35 | Rat | triadimefon | decreases expression | EXP | | 6480464 | triadimefon results in decreased expression of ZFP35 mRNA | CTD | PMID:30047161 | Zfp35 | Rat | triphenyl phosphate | affects expression | ISO | ZNF79 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ZNF79 mRNA | CTD | PMID:37042841 | Zfp35 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ZFP35 mRNA | CTD | PMID:23034163 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















